PEAK6 Investments’s Immunogen Inc IMGN Stock Holding History

PEAK6 Investments’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,500	Closed	-$222K	–	4927
2023 Q4	$222K	Sell	7,500 -9,900	-57%	-$197K	﹤0.01%	3180
2023 Q3	$276K	Buy	17,400 +7,500	+76%	+$125K	﹤0.01%	2848
2023 Q2	$187K	Buy	+9,900	New	+$117K	﹤0.01%	2920
2022 Q3	–	Sell	-9,900	Closed	-$187K	–	6384
2022 Q2	$187K	Buy	+9,900	New	+$43K	﹤0.01%	4814

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PEAK6 Investments's IMGN Position: Q4 2023 in Review

PEAK6 Investments sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 4,527 shares — an estimated $90.1K sold.

PEAK6 Investments first reported a position in IMGN in Q1 2023 and held it in 2 quarters. The position peaked at $76.8K in Q1 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

PEAK6 Investments reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
PEAK6 Investments sold 4,527 Immunogen Inc shares in Q4 2023, an estimated $90.1K.
PEAK6 Investments first reported a position in Immunogen Inc in Q1 2023 and held it in 2 quarters.
PEAK6 Investments's Immunogen Inc position peaked at $76.8K in Q1 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.